Former director of the PATH Malaria Vaccine Initiative, Christian Loucq, M.D., says it is exciting to see Dinglasan’s concept moving toward a clinical trial. “There are very interesting issues to be addressed in this project which span the technical, immunological, strategic, regulatory and behavioral,” says Dr. Loucq, who also formerly directed the International Vaccine Institute. […]
Read More
First in human clinical trials of the AnAPN1 malaria transmission-blocking vaccine
- March 31, 2021
- Comments off